Conditions: Infections, Herpesviridae
Keywords: viral shedding Recurrent herpes genital herpes
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 73
Healthy volunteers: yes

Brief summary:
Eligible subjects will be randomized to receive VALTREX® tablet 1g or placebo once daily for 60 days in a two-way crossover study with a washout period of 7 days between treatment periods.

Detailed description:

Arms:
arm 1: VALTREX 1 g once daily, Placebo arm 2: Placebo, VALTREX 1 g once daily

Interventions: intervention 1: Valaciclovir intervention 2: Placebo
Intervention descriptions: intervention 1: Valtrex 1g once daily intervention 2: placebo

Protocol document: